INAB
In8bio Inc
NASDAQ: INAB · HEALTHCARE · BIOTECHNOLOGY
$1.47
-2.65% today
Updated 2026-04-30
Market cap
$15.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.44
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
In8bio Inc (INAB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.77M | $-4.80M | $-7.13M | $-13.51M | $-24.12M | $-23.34M | $-24.15M | $-12.71M |
| Capital expenditures | $757000.00 | $330000.00 | $309000.00 | $309000.00 | $3.71M | $600000.00 | $104000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $31000.00 | $76000.00 | $357000.00 | $2.19M | $3.47M | $4.37M | $5.00M | $3.19M |
| Free cash flow | $-3.53M | $-5.13M | $-7.44M | $-13.82M | $-27.83M | $-23.94M | $-24.25M | $-12.71M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |